Related Experiment Videos
Outcome and prognosis in retroperitoneal soft tissue sarcoma
C N Catton1, B O'Sullivan, C Kotwall
1Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Canada.
Summary
Complete surgical removal is key for retroperitoneal soft tissue sarcoma (RSTS) survival. While adjuvant irradiation may delay local recurrence, new strategies are needed for improved outcomes in RSTS patients.
Area of Science:
- Oncology
- Surgical Oncology
- Radiation Oncology
Background:
- Retroperitoneal soft tissue sarcomas (RSTS) are rare and challenging malignancies.
- Treatment outcomes for RSTS have historically been limited, with local control being a significant challenge.
Purpose of the Study:
- To retrospectively evaluate treatment outcomes for patients with RSTS.
- To identify prognostic factors for survival, locoregional disease control, and distant metastasis in RSTS.
Main Methods:
- Retrospective review of 104 RSTS patients treated with surgery and irradiation (1975-1988).
- Univariate log-rank analysis to assess prognostic factors.
- Evaluation of surgical completeness, adjuvant radiotherapy, chemotherapy, histology, and patient demographics.
Main Results:
- Complete surgical excision was the only significant factor improving survival and disease control (locoregional and distant).
- Liposarcoma histology and younger age (<62 years) were associated with improved survival.
- Adjuvant irradiation after complete surgery showed a trend towards prolonged locoregional relapse-free survival (RFR).
Conclusions:
- Failure in local control is the primary driver of treatment failure in RSTS.
- Postoperative irradiation, even at doses >35 Gy, only delayed local recurrence after complete surgery.
- Novel treatment strategies, such as preoperative irradiation combined with aggressive surgical excision, are warranted for RSTS.